6 CCR 1009-9
DEPARTMENT OF PUBLIC HEALTH AND ENVIRONMENT Disease Control and Environmental Epidemiology Division RULES PERTAINING TO REPORTING, PREVENTION AND CONTROL OF AIDS, HIV RELATED ILLNESS AND HIV INFECTION 6 CCR 1009-9 [Editor’s Notes follow the text of the rules at the end of this CCR Document.] Colorado has a comprehensive public health AIDS/HIV control law: Colorado Revised Statutes Title 25, Article 4, Sections 1401 et seq. These regulations are intended to provide detail and clarification for selected parts of the above cited statute. The statute covers subject matters not included in these regulations.
C.R.S. 25-4-1405.5 (2) (a) (I) requires the Colorado Department of Public Health and Environment (CDPHE) to conduct an anonymous counseling and testing program for persons considered to be at high risk for infection with HIV. The provision of confidential counseling and testing for HIV is the preferred screening service for detection of HIV infection. Local boards of health who provide HIV counseling and testing through a contractual agreement with CDPHE must consider the need for an anonymous HIV testing option in their jurisdiction. The consideration of this option must provide an opportunity for public comment in a public forum at a minimum of every two years. Other mechanisms for input into the need for an anonymous testing option in that jurisdiction must be available in addition to the public forum, including anonymous testimony in writing or through an organization. Local boards of health must document the following: notification of interested parties and the public, time allowed between notification and the public forum, accessibility in both location and time of the public forum, and the response to public comment in the decision process. Local Boards of Health electing to provide confidential HIV testing with an anonymous option must do so in conjunction with publicly funded HIV testing and counseling projects that screen individuals for HIV infection without providing on-going health care. The term “publicly funded HIV testing and counseling projects,” shall pertain to HIV testing and counseling projects that receive direct funding support from the CDPHE, or receive direct funding support for analogous HIV testing and counseling projects from the following federal agencies: U.S. Department of Health and Human Services (DHHS), Centers for Disease Control and Prevention (CDC); Health Resources and Services Administration (HRSA), Ryan White HIV/AIDS Treatment Extension Act of 2009; or the Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Prevention. The term “health-care setting,” shall refer to hospitals, emergency departments, urgent-care clinics, inpatient services, sexually transmitted disease (STD) clinics or other venues offering clinical STD services, tuberculosis (TB) clinics, substance abuse treatment clinics, other public health clinics, community clinics, correctional health-care facilities, primary care settings, or private physicians offices. Per C.R.S. 25-4-1405.5 (2) (a) (II), Regulations 6-8 are the performance standards for confidential and anonymous publicly funded HIV testing and counseling projects and CDPHE staff. Regulation 1. Reporting By Physicians, Health Care Providers, Hospitals, And Others Diagnosed cases of AIDS, HIV-related illness, and HIV infection, regardless of whether confirmed by laboratory tests, shall be reported to the state or local health department or health agency within 7 days of diagnosis by physicians, health care providers, hospitals, or any other person providing testing and/or counseling or treatment to a person with HIV infection. When hospitals and laboratories transmit disease reports electronically using systems and protocols developed by the department that ensure protection of confidentiality, such reporting is acceptable and is considered good faith reporting. All cases are to be reported with the patient's name, date of birth, sex, race, ethnicity, address (including city and county), phone, name and address of the reporting physician or agency; and such other information as is needed to identify and locate the patient for follow up. For cases reported from a public anonymous testing site as provided by C.R.S. 25-4-1405.5, the patient's name and address and the name and address of the reporting physician are not required. Reports on hospitalized patients may be made part of a report by the hospital as a whole. The reporting of the name, phone, address, date of birth, sex, race or ethnicity of research subjects with AIDS, HIV-related illness, or HIV infection to CDPHE or local department of health pursuant to the provisions of Sections 25-4-1402 and 25-4-1403 shall not be required of any researcher conducting a behavioral research study, medical research study of HIV treatment or vaccine effectiveness or conducting basic biomedical research into the cellular mechanisms causing HIV infection or HIV-related disease pursuant to an approved research protocol. For the purposes of the research exemption authorized in this section, “approved research protocol” means any activity which has been reviewed and approved by the state Board of Health as a research protocol. The research exemption authorized in this section and which meets the criteria described in 1. (A) through (F) inclusive, does not alter the reporting requirements of persons and researchers otherwise required to make reports when engaged in any treatment or testing outside the scope of or prior to enrollment in an approved research protocol and does not exempt the researcher from reporting other reportable diseases. The research exemption authorized in this section does not exempt medical researchers from meeting the requirements of Section 25-4-1405 (5) to provide post-test counseling to infected enrolled research subjects and referral of such subjects to the state department of public health and environment or local department of health for partner notification services.
The State Board of Health shall approve research activities for the research reporting exemption specified in this section based on evidence that the research activity for which an exemption is requested meets the eligibility requirements specified by the State Board of Health. The State Board of Health shall consider the following eligibility requirements:
(A) is fully described by a research protocol;
(B) is subject to review by and is governed by the federal department of Health and Human Services;
(C) has as the protocol objectives either: the investigation of HIV behavioral research, the effectiveness of a medical therapy or vaccine in preventing infection or the progression of HIV-related disease, or basic medical research into the cellular mechanisms causing HIV infection or HIV-related disease;
(D) is reviewed and approved by a duly constituted institutional review board in accordance with the regulations established by the Secretary of the Federal Department of Health and Human Services;
(E) the researcher has provided information that the research activity will be facilitated by an exemption specified in this section; and (F) has been determined to have potential health benefits. Regulation 2. Reporting by Laboratories Laboratories shall report every test result that is diagnostic of, or highly correlated with, or indicates HIV infection, including, but not limited to, any undetectable HIV viral load and HIV genotype testing. The report shall include the name, date of birth, sex, race and address (including city and county), phone of the individual from whom the specimen was submitted. Such test results shall be reported by all in-state laboratories and by out-of-state laboratories that maintain an office or collection facility in Colorado or arrange for collection of specimens in Colorado. Results must be reported by the laboratory which performs the test, but an in-state laboratory which sends specimens to an out-of-state referral laboratory is also responsible for reporting the results. The laboratory shall also report the name, address and phone of the attending physician and any other person or agency referring such specimen for testing. Laboratories should make efforts to report all HIV/AIDS-related tests electronically whenever possible. All genotype testing must be reported in an electronic format (such as a FASTA file) containing the nucleotide sequences of HIV.
When associated with other clinical or laboratory evidence of HIV infection, the Board of Health defines a CD4 test result of either CD4 count <500 mm3or CD4% < 29% as a primary immunologic measure indicating severe HIV infection and, when the count is < 200 mm 3, as defining AIDS. Laboratories shall report CD4 counts < 500 mm3 OR CD4% < 29%. The Department shall destroy personal identifying information on all persons with CD4 results in the reportable range if investigation subsequent to the report finds no evidence of HIV infection. Laboratories may fulfill the requirement to report CD4 counts < 500 mm3or CD4% < 29% by allowing authorized personnel of CDPHE access to such records. Laboratories shall follow the same procedures for reporting as are required of other reporting sources in Regulation 1.
Report of test results by a laboratory does not relieve the attending physician or other person providing HIV testing and/or counseling of his/her obligation to report the case or diagnosis, nor does report by the physician or other person providing HIV testing and/or counseling relieve the laboratory of its obligation. Regulation 3. Information Sharing Information concerning cases of AIDS, HIV-related illness, or HIV infection shall be shared between the appropriate local health department or health agency and CDPHE, as provided by C.R.S. 25-4-1404 (1) (B), and in a timely manner, usually within the timeframe for reporting in Regulation 1. These requirements shall not apply if the state and local health agencies mutually agree not to share information on reported cases.
Regulation 4. Confidentiality All public health reports and records held by the state or local health department in compliance with these regulations shall be confidential information subject to C.R.S. 25-4-1404. The public health reports and records referred to in C.R.S. 25-4-1404 shall include, but not be limited to, the forms and records designated by CDPHE for institutions and agencies which screen individuals for HIV infection without providing ongoing health care, such as a publicly funded HIV testing and counseling project. Reasonable efforts shall be made by the department to consult with the attending physician or medical facility caring for the patient prior to any further follow-up by state or local health departments or health agencies.
Regulation 5. Investigations to Confirm the Diagnosis and Source of HIV Infection and to Prevent HIV Transmission It is the duty of state and local health officers to conduct investigations to confirm the diagnosis and sources of HIV infection and to prevent transmission of HIV. Such investigations shall be considered official duties of the health department or health agency. Such investigations may include, but are not limited to:
1. review of pertinent, relevant medical records by authorized personnel if necessary to confirm the diagnosis, to investigate possible sources of infection, to determine objects and materials potentially contaminated with HIV and persons potentially exposed to HIV. Such review of records may occur without patient consent and shall be conducted at reasonable times and with such notice as is reasonable under the circumstances;
2 performing follow-up interview(s) with the case or persons knowledgeable about the case to collect pertinent and relevant information about the sources of HIV infection, materials and objects potentially contaminated with HIV, and persons who may have been exposed to HIV. Regulation 6. Objective Standards A. Training
B. Notification of Results
C. Partner Notification If CDPHE staff provides partner notification for a publicly funded HIV testing and counseling project, then the following standards do not apply.
Regulation 7. Operational Standards A. Publicly Funded Testing and Counseling
B. Consent Form A consent form must be used at all publicly funded HIV testing and counseling projects in non health-care settings.
C. Testing Parameters
D. Written Results
E. Confidentiality and Record Maintenance
Regulation 8. Evaluation Standards and Penalties A. Each CDPHE funded HIV testing and counseling project’s compliance with these standards will be evaluated by the following:
B. Failure of a CDPHE funded HIV testing and counseling project to comply with and meet these standards may result in one or more of the following action(s):